Finally, you can test yourself where and when it´s most convenient for you: with our test kit, you can make a qualitative in vitro diagnostic of the SARS-CoV-2 antigen by means of a simple smear in the anterior nose area – even if you have no medical/clinical experience. Thanks to precise step-by-step instructions, carrying out the test is dead easy.
The test result is available within 15 minutes.
Easy handling and long? shelf life due to extended temperature range.
Smear in the anterior nasal cavity, nasopharyngeal and pharyngeal.
Wash your hands thoroughly with soap (at least 30 seconds)
Remove the nasal swab from the package
Gently insert the swab 2–4 cm into the nostril
Roll the swab 5 times along the nasal mucosa, repeat the procedure with the same swab in the other nostril
Unscrew the lid of the sample tube
Insert the swab into the tube, turn 10 times and squeeze the base of the tube
Let the sample tube with the swab rest in the holder of the packaging for one minute
Squeeze the tube a few times with two fingers
Screw the lid on the sample tube and break off the tip of the lid
Take the test cassette from the sealed bag and place it on a flat, clean and dry surface
Add 2–3 drops of the solution from the sample tube into the recess of the test cassette
The result will appear after 10–15 minutes
A control line (C) and no test line (T) appears on the test cassette
No control line (C) appears on the test cassette. An appearance of the test line (T) is irrelevant here
Both a control line (C) and a test line (T) appear on the test cassette
100% reliability cannot be guaranteed by a rapid antigen test; however, this can also occur with other test methods, such as PCR tests. Using the PCR test as the sole diagnostic method quickly reaches economic proportions (laboratory equipment, costs etc.) that the global health system cannot afford due to the number of infections. COVID-19 rapid tests provide a useful supportive alternative.
COVID-19 rapid tests can be carried out cost-effectively, decentrally and by any healthcare professional – or even as self-tests by the general public. No additional equipment is necessary, as is the case with a complex PCR smear test.
Currently, COVID-19 rapid tests are used in nursing homes, hospitals or schools for regular testing of staff and residents. In test centers, all citizens can be tested by medical professionals. Self-tests can provide additional security in specific, every-day situations – for example, before visiting friends and family, when eating out, or before visiting the theatre or cinema. If a COVID-19 rapid test is positive, the result must be confirmed by a PCR test.
The sensitivity of a diagnostic test procedure indicates the percentage of sick patients who actually detect the corresponding disease by test application. This is calculated as a quotient of right-positive test results and the sum of right-positive and false-negative test results. The higher the sensitivity, the more reliably the disease is diagnosed.
The specificity of a diagnostic test procedure indicates the probability with which healthy test persons are also recognized as healthy in the test. This is calculated as a quotient of indeed-negative test results and the sum of false-positive and right-negative test results.
In order to ensure the reliable detection of a transmission-relevant infection, the detection limit of the antigen tests should be based on the data collected so far by the RKI. The detection limit describes the extreme value of a measurement method up to which the corresponding measured quantity can barely be detected.